About Ramathibodi Hospital; Dept of Med.-Div. of Med. Onc
โรงพยาบาลรามาธิบดี เป็นหน่วยงานหนึ่งในระดับภาควิชาของคณะแพทยศาสตร์โรงพยาบาลรามาธิบดี มหาวิทยาลัยมหิดล สังกัดกระทรวงการอุดมศึกษา วิทยาศาสตร์ วิจัยและนวัตกรรม และเป็นสถานพยาบาลแห่งหนึ่งของรัฐ ตั้งอยู่เลขที่ 270 ถนนพระราม 6 แขวงทุ่งพญาไท เขตราชเทวี กรุงเทพมหานคร 10400 มีเนื้อที่ทั้งหมด 38 ไร่ มีอาคารรวม 20 อาคาร ...
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Ramathibodi Hospital; Dept of Med.-Div. of Med. Onc
During the past decade, Ramathibodi Hospital; Dept of Med.-Div. of Med. Onc conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 9 clinical trials were completed, i.e. on
average, 47.4% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 5 clinical trials were completed. i.e. 55.6%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Ramathibodi Hospital; Dept of Med.-Div. of Med. Onc"
#1 collaborator was "Genentech, Inc." with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Ramathibodi Hospital; Dept of Med.-Div. of Med. Onc
According to Clinical.Site data, the most researched conditions in "Ramathibodi Hospital; Dept of Med.-Div. of Med. Onc" are
"Breast Cancer" (4 trials), "Non-Small Cell Lung Cancer" (2 trials), "Advanced or Metastatic Esophageal Squamous Cell Carcinoma" (1 trials), "Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Ramathibodi Hospital; Dept of Med.-Div. of Med. Onc" in a lesser frequency.
Clinical Trials Intervention Types at Ramathibodi Hospital; Dept of Med.-Div. of Med. Onc
Most popular intervention types in "Ramathibodi Hospital; Dept of Med.-Div. of Med. Onc" are "Drug" (23 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Atezolizumab" (9 trials), "Docetaxel" (5 trials), "Cisplatin" (4 trials) and "Tiragolumab" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Ramathibodi Hospital; Dept of Med.-Div. of Med. Onc
The vast majority of trials in "Ramathibodi Hospital; Dept of Med.-Div. of Med. Onc" are
21 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Ramathibodi Hospital; Dept of Med.-Div. of Med. Onc
Currently, there are NaN active trials in "Ramathibodi Hospital; Dept of Med.-Div. of Med. Onc".
undefined are not yet recruiting,
7 are recruiting,
6 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Ramathibodi Hospital; Dept of Med.-Div. of Med. Onc,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Ramathibodi Hospital; Dept of Med.-Div. of Med. Onc, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 20 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".